Humana ABFRA:47H +2.77%73 EBITDA Margin % is 10.04% as of Mar. 2026, which is 0% above its 10-year median of 10.03. GuruFocus rates FRA:47H with a GF Score™ of 73/100 and a GF Value™ of €3.23. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Humana AB ranks better than 51.2% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Humana AB's EBITDA for the
three
months ended in Mar. 2026 was €23.1 Mil. Humana AB's Revenue for the
three
months ended in Mar. 2026 was €230.1 Mil. Therefore, Humana AB's EBITDA margin for the quarter that ended in Mar. 2026 was 10.04%.
Humana AB (FRA:47H) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Humana AB EBITDA Margin % Related Terms
Humana AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Humana AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:47H vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Humana AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Humana AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana AB (FRA:47H) has a EBITDA Margin % of 10.04% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Humana AB and its competitors. This is near median its historical median of 10.03. Over the past decade, Humana AB's EBITDA Margin % has ranged from 5.75 to 11.14. According to the industry distribution chart, Humana AB ranks #326 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 48.8%.
Is Humana AB's EBITDA Margin % too high?
Humana AB's current EBITDA Margin % of 10.04% is near median its 10-year median of 10.03. Over the past 10 years, this metric has ranged from a low of 5.75 to a high of 11.14. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Humana AB's value of 10.04% is 1.7% below this industry median. Based on the distribution chart, Humana AB ranks #326 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Humana AB has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Humana AB's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #326 out of 668 companies for EBITDA Margin %. This puts Humana AB in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Humana AB's value of 10.04% is 1.7% below this benchmark. Historically, Humana AB's own EBITDA Margin % has ranged from 5.75 to 11.14 over the past decade. While the company's 10-year median is 10.03 vs. the industry median of 10.21, Humana AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana AB's current EBITDA Margin % of 10.04% is 1.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Humana AB and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current EBITDA Margin % is 10.04%, which is near median its own 10-year median of 10.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Humana AB (FRA:47H) has a current EBITDA Margin % of 10.04%. The stock's GF Value™ is €3.23, compared to a current price of €4.27 — trading 32.2% above its estimated fair value. The current EBITDA Margin % is 10.04%, which is near median its 10-year median of 10.03 and 1.7% below the Healthcare Providers & Services industry median of 10.21. Humana AB's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Humana AB (FRA:47H), the current EBITDA Margin % is 10.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (FRA:47H) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of €4.27 is trading 32.2% above its estimated GF Value™ of €3.23.
Key valuation signals for FRA:47H:
EBITDA Margin %: 10.04% (near median its 10-year median of 10.03)
GF Value™: €3.23 vs. price of €4.27 (32.2% above fair value)
Industry Position: 1.7% below the Healthcare Providers & Services median (#326 of 668)
No single metric tells the full story. See the FRA:47H stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
73GF Score
Get the complete analysis for FRA:47H
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:47H has been successfully added to your 
